Bioclinica's Clinical Adjudication Service provides a key role in determining the efficacy and safety endpoints needed to analyze clinical trial outcomes, which are necessary in determining clinical trial success.
Flexible modeling of any adjudication pathway coupled with transparency of workflow status along with immediate data accessibility
Determining acceptable safety results during a clinical trial by way of independent electronic event adjudication committees is the most efficient process to assist sponsors in reducing costs, increasing quality, and eliminating clinical bias. Bioclinica's Clinical Adjudication Service provides sponsors with the ability to electronically manage safety endpoints from notification of an endpoint at a clinical trial site through central review by therapeutic experts. This allows for an efficient and streamlined process that ensures high quality and timely results. Therapeutic expertise backed by automated technology enables continuous adjudication with real-time results.
Bioclinica's Clinical Adjudication Service is completely customizable in order to best meet a sponsor's adjudication requirements. Our vast library of eCRF logic and safety and efficacy parameters is designed to meet adjudicator, sponsor, and regulatory data delivery compliance needs.
Bioclinica's Clinical Adjudication Service benefits to a sponsor: